Greek English

Contracted laboratory for Biomarkers

BIOANALYTICA GENOTYPE SA was established in December 2004 as a biotech startup aiming to provide specialised molecular cytogenetic research and application services to the biomedical Community.

 

Was funded by BIOANALYTICA SA, a leading stakeholder in the greek market for molecular diagnostics and laboratory infrastructure, and by the researcher Dr. Georgia Bardi, Associate Professor of Experimental Clinical Genetics at the Medical school of Lund University, Sweden and former Director of the Cytogenetics facility at Saint Savas Oncology hospital of Athens.

 

Is co-financed by the Greek General Secretariat of Research and Technology under the 3rd Community Support Program (03 Praxe 26).

 

 

Bioanalytical-GenoTypos s.a: Participation in the 24th International Colloquium on Viral Hepatitis B and C "F. Hatzigiannis '

Bioanalytical-GenoTypos s.a: Participation in the 24th International Colloquium on Viral Hepatitis B and C "F. Hatzigiannis '

Βιοαναλυτική

The Bioanalytical-GenoTypos participated with a booth in the 24th International Colloquium on Viral Hepatitis B and C "F. Hatzigiannis on 28 29 & January 2017.

 

The Bioanalytical-GenoTypos SA with the two new services that performs the Gonotypisi of hepatitis C with NGS and non-invasive liver control with Fibroscan and FibroTest offers the most comprehensive investigation and monitoring of liver disease with Molecular, Imaging,

 

Biochemistry Immunological control &. The Bioanalytical-GenoTypos SA is a laboratory contracted by the REGULATIONS. * Echosens: + probe for obese people

Biochemistry Immunological control &. The Bioanalytical-GenoTypos SA is a laboratory contracted by the REGULATIONS. * Echosens: + probe for obese people

BioAnalytica-Genotype SA serves the healthcare market by offering Cytogenetics and Molecular Genetics tests, designed to answer questions related to diagnosis, prognosis and therapy selection for hematologic and solid tumor cancers.